参考文献/References:
[1] 陈伟伟,高润霖,刘力生,等. 《中国心血管病报告2017》概要[J].中国循环杂志, 2018,33(1):1-8.
[2] Herdy AH, Ritt LE, Stein R, et al. Cardiopulmonary exercise test:background, applicability and interpretation[J]. Arq Bras Cardiol, 2016,107(5):467-481.
[3] Guazzi M, Arena R, Halle M, et al. 2016 focused update:clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations[J]. Circulation, 2016,133(24):e694-711.
[4] Ross R, Blair SN, Arena R, et al. Importance of assessing cardiorespiratory fitness in clinical practice:a case for fitness as a clinical vital sign:a scientific statement from the American Heart Association[J].Circulation, 2016,134(24):e653-653e699.
[5] Guazzi M, Arena R, Halle M, et al. 2016 focused update: clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations[J]. Eur Heart J, 2018,39(14):1144-1161.
[6] Letnes JM, Dalen H, Vesterbekkmo EK, et al. Peak oxygen uptake and incident coronary heart disease in a healthy population: the HUNT Fitness Study[J]. Eur Heart J, 2019,40(20):1633-1639.
[7] Chaudhry S, Arena RA, Hansen JE, et al. The utility of cardiopulmonary exercise testing to detect and track early-stage ischemic heart disease[J]. Mayo Clin Proc, 2010,85(10):928-932.
[8] Mazaheri R, Shakerian F, Vasheghani-Farahani A, et al. The usefulness of cardiopulmonary exercise testing in assessment of patients with suspected coronary artery disease[J]. Postgrad Med J, 2016,92(1088):328-332.
[9] Dominguez-Rodriguez A, Abreu-Gonzalez P, Gomez MA, et al. Myocardial perfusion defects detected by cardiopulmonary exercise testing:role of VE/VCO2 slope in patients with chest pain suspected of coronary artery disease[J]. Int J Cardiol, 2012,155(3):470-471.
[10] Dominguez-Rodriguez A, Abreu-Gonzalez P, Gomez MA, et al. Assessing coronary artery disease in patients with anginal chest pain and left bundle branch block:an emerging role for a new parameter of cardiopulmonary exercise testing[J]. Crit Pathw Cardiol, 2012,11(4):214-217.
[11] Belardinelli R, Lacalaprice F, Tiano L, et al. Cardiopulmonary exercise testing is more accurate than ECG-stress testing in diagnosing myocardial ischemia in subjects with chest pain[J]. Int J Cardiol, 2014,174(2):337-342.
[12] Belardinelli R, Lacalaprice F, Carle F, et al. Exercise-induced myocardial ischaemia detected by cardiopulmonary exercise testing[J]. Eur Heart J, 2003,24(14):1304-1313.
[13] Guazzi M, Adams V, Conraads V, et al. EACPR/AHA Scientific Statement. Clinical recommendations for cardiopulmonary exercise testing data assessment in specific patient populations[J].Circulation, 2012,126(18):2261-2274.
[14] Laukkanen JA, Kurl S, Salonen JT, et al. Peak oxygen pulse during exercise as a predictor for coronary heart disease and all cause death[J]. Heart, 2006,92(9):1219-1224.
[15] Popovic D, Martic D, Djordjevic T, et al. Oxygen consumption and carbon-dioxide recovery kinetics in the prediction of coronary artery disease severity and outcome[J]. Int J Cardiol, 2017,248:39-45.
[16] Popovic D, Damjanovic S, Djordjevic T, et al. Stress hormones at rest and following exercise testing predict coronary artery disease severity and outcome[J]. Stress, 2017,20(5):523-531.
[17] de Lorenzo A, da SCL, FCC S, et al. Clinical, scintigraphic, and angiographic predictors of oxygen pulse abnormality in patients undergoing cardiopulmonary exercise testing[J]. Clin Cardiol, 2017,40(10):914-918.
[18] Zheng HC, Ding YY, Sun XG, et al. Assessment of overall function after percutaneous coronary intervention by cardiopulmonary exercise testing in patients with stable coronary heart disease[J]. Zhongguo Ying Yong Sheng Li Xue Za Zhi, 2015,31(4):378-382.
[19] Abdullah SM, Hastings JL, Amsavelu S, et al. Percutaneous coronary intervention of coronary chronic total occlusions improves peak oxygen uptake during cardiopulmonary exercise testing[J].J Invasive Cardiol, 2017,29(3):83-91.
[20] Harber MP, Kaminsky LA, Arena R, et al. Impact of cardiorespiratory fitness on all-cause and disease-specific mortality:advances since 2009[J]. Prog Cardiovasc Dis, 2017,60(1):11-20.
[21] Nichols S, Taylor C, Page R, et al. Is cardiorespiratory fitness related to cardiometabolic health and all-cause mortality risk in patients with coronary heart disease? A CARE CR Study[J]. Sports Med Open, 2018,4(1):22.
[22] Kunutsor SK, Kurl S, Khan H, et al. Associations of cardiovascular and all-cause mortality events with oxygen uptake at ventilatory threshold[J]. Int J Cardiol, 2017,236:444-450.
[23] Laukkanen JA, CGS A, Kurl S, et al. Relative peak exercise oxygen pulse is related to sudden cardiac death, cardiovascular and all-cause mortality in middle-aged men[J]. Eur J Prev Cardiol, 2018,25(7):772-782.
[24] Hagn?s MJ, Kurl S, Rauramaa R, et al. The value of cardiorespiratory fitness and exercise-induced ST segment depression in predicting death from coronary heart disease[J]. Int J Cardiol, 2015,196:31-33.
[25] Hansen D, Dendale P, Coninx K, et al. The European Association of Preventive Cardiology Exercise Prescription in Everyday Practice and Rehabilitative Training (EXPERT) tool: A digital training and decision support system for optimized exercise prescription in cardiovascular disease. Concept, definitions and construction methodology[J]. Eur J Prev Cardiol, 2017,24(10):1017-1031.
[26] Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America[J]. Circulation, 2017,136(6):e137-137e161.
[27] McGREGOR G, Gaze D, Oxborough D, et al. Reverse left ventricular remodeling: effect of cardiac rehabilitation exercise training in myocardial infarction patients with preserved ejection fraction[J]. Eur J Phys Rehabil Med, 2016,52(3):370-378.
[28] SJJ T, Allen JC, Tan SY. Determination of ideal target exercise heart rate for cardiac patients suitable for rehabilitation[J]. Clin Cardiol, 2017,40(11):1008-1012.
[29] Popovic D, Kumar N, Chaudhry S, et al. Improvements in key cardiopulmonary exercise testing variables following cardiac rehabilitation in patients with coronary artery disease[J]. J Cardiopulm Rehabil Prev, 2018,38(5):E5-5E8.
[30] Sunamura M, Ter HN, van den Berg-Emons RJG, et al. Cardiac rehabilitation in patients with acute coronary syndrome with primary percutaneous coronary intervention is associated with improved 10-year survival[J]. Eur Heart J Qual Care Clin Outcomes, 2018,4(3):168-172.
相似文献/References:
[1]杜钧,佘强.冠心病抗炎治疗的临床研究进展[J].心血管病学进展,2016,(1):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
DU Jun,SHE Qiang.Clinical Research Progress of Anti-inflammatory Therapy of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2016,(9):32.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.009]
[2]努热曼古丽·阿布都克热木,马依彤.重度左心室收缩功能不全的冠心病患者血运重建治疗疗效及预后的评价[J].心血管病学进展,2016,(1):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
NUREMANGULI·Abudukeremu,MA Yitong.Evaluation of Efficacy and Prognosis of Revascularization Therapy on Patients
with Coronary Heart Disease and Severe Left Ventricular Systolic Dysfunction[J].Advances in Cardiovascular Diseases,2016,(9):46.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.012]
[3]刘洋,综述,伍贵富,等.增强型体外反搏治疗冠心病的新机制[J].心血管病学进展,2016,(2):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
LIU Yang,WU Guifu.New Mechanism of Enhanced External Counterpulsation for
Treatment of Coronary Artery Disease[J].Advances in Cardiovascular Diseases,2016,(9):185.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.023]
[4]杨洋,综述,沈比先,等.心脏核磁共振评估缺血性心脏病的应用价值[J].心血管病学进展,2016,(2):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
YANG Yang,SHEN Bixian.Value of Cardiac Magnetic Resonance Assessment of Ischemic Heart Disease[J].Advances in Cardiovascular Diseases,2016,(9):204.[doi:10.16806/j.cnki.issn.1004-3934.2016.02.028]
[5]史敬,综述,马依彤,等.n-3多不饱和脂肪酸对心血管疾病的临床应用[J].心血管病学进展,2016,(3):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
SHI Jing,MA Yitong.Effects of n-3 Polyunsaturated Fatty Acids on Cardiovascular Disease[J].Advances in Cardiovascular Diseases,2016,(9):278.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.016]
[6]高柳,袁晋青.重复支架置入术治疗药物洗脱支架再狭窄的研究进展[J].心血管病学进展,2015,(5):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
GAO Liu,YUAN Jingqing.Progress in Treatment for Drug-eluting Stent Restenosis by
Re-implementation of Stents[J].Advances in Cardiovascular Diseases,2015,(9):555.[doi:10.3969/j.issn.1004-3934.2015.05.008]
[7]邓文政,邓平.MG53蛋白的研究进展[J].心血管病学进展,2015,(5):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
DENG Wenzheng,DENG Ping.Research Progress of MG53[J].Advances in Cardiovascular Diseases,2015,(9):626.[doi:10.3969/j.issn.1004-3934.2015.05.027]
[8]陈静,李兴德.冠心病患者服药依从性的研究进展[J].心血管病学进展,2015,(6):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
CHEN Jing,LI Xingde.Advances in Medication Adherence of Patients with Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2015,(9):728.[doi:10.3969/j.issn.1004-3934.2015.06.018]
[9]姚雯,毛露,孙硕,等.心源性外泌体作为冠心病标志物和新靶点展望[J].心血管病学进展,2019,(6):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
YAO Wen,MAO Lu,SUN Shuo,et al.Exogenous Exosome as A New Marker and Target of Coronary Heart Disease[J].Advances in Cardiovascular Diseases,2019,(9):844.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.002]
[10]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(9):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]